رجوع
37
نطاق اليوم
KWD 19.13
KWD 19.57
نطاق 52 أسبوعًا
KWD 9.13
KWD 22.98
حجم التداول
536,454
متوسط 50 يوم / 200 يوم
KWD 19.94
/
KWD 17.19
الإغلاق السابق
KWD 19.53
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 23.1 | 0.3 |
| P/B | 2.7 | 2.9 |
| ROE % | 11.7 | 3.7 |
| Net Margin % | 3.2 | 3.8 |
| Rev Growth 5Y % | 2.9 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 23.330
+20.4%
Low: KWD 22.000
High: KWD 25.000
مكرر الربحية المستقبلي
20.3
ربحية السهم المستقبلية
KWD 0.964
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
1.9 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 1.327
KWD 1.323 – KWD 1.331
|
2.1 B | 1 |
| FY2027 |
KWD 1.098
KWD 1.095 – KWD 1.101
|
2 B | 3 |
| FY2026 |
KWD 0.964
KWD 0.961 – KWD 0.967
|
1.9 B | 3 |
النقاط الرئيسية
Revenue grew 2.85% annually over 5 years — modest growth
Earnings grew 49.63% over the past year
ROE of 11.69% — decent returns on equity
Debt/Equity of 0.05 — conservative balance sheet
Generating 139.15M in free cash flow
PEG of 0.45 suggests growth is underpriced
النمو
Revenue Growth (5Y)
2.85%
Revenue (1Y)7.08%
Earnings (1Y)49.63%
FCF Growth (3Y)91.13%
الجودة
Return on Equity
11.69%
ROIC6.81%
Net Margin3.21%
Op. Margin2.64%
الأمان
Debt / Equity
0.05
Current Ratio3.38
Interest Coverage30.72
التقييم
P/E Ratio
23.12
P/B Ratio2.68
EV/EBITDA25.32
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.08% | Revenue Growth (3Y) | 4.84% |
| Earnings Growth (1Y) | 49.63% | Earnings Growth (3Y) | 24.04% |
| Revenue Growth (5Y) | 2.85% | Earnings Growth (5Y) | 5.02% |
| Profitability | |||
| Revenue (TTM) | 1.84B | Net Income (TTM) | 59.06M |
| ROE | 11.69% | ROA | 7.31% |
| Gross Margin | 13.03% | Operating Margin | 2.64% |
| Net Margin | 3.21% | Free Cash Flow (TTM) | 139.15M |
| ROIC | 6.81% | FCF Growth (3Y) | 91.13% |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 3.38 |
| Interest Coverage | 30.72 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 23.12 | P/B Ratio | 2.68 |
| P/S Ratio | 0.74 | PEG Ratio | 0.45 |
| EV/EBITDA | 25.32 | Dividend Yield | 0.00% |
| Market Cap | 1.37B | Enterprise Value | 1.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.84B | 1.72B | 1.67B | 1.69B | 1.64B |
| Net Income | 59.06M | 39.47M | 38.39M | 34.24M | 48.54M |
| EPS (Diluted) | 0.81 | 0.53 | 0.52 | 0.46 | 0.65 |
| Gross Profit | 239.41M | 228.09M | 214.75M | 193.31M | 230.57M |
| Operating Income | 48.54M | 53.27M | 54.66M | 43.79M | 64.13M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 807.78M | 815.47M | 803.18M | 718.33M | 786.80M |
| Total Liabilities | 297.57M | 315.55M | 346.57M | 292.16M | 334.12M |
| Shareholders' Equity | 510.21M | 499.93M | 456.62M | 426.17M | 452.68M |
| Total Debt | 24.68M | 16.43M | 43.64M | 33.10M | 17.80M |
| Cash & Equivalents | 161.12M | 85.24M | 54.33M | 26.28M | 70.79M |
| Current Assets | 576.42M | 556.65M | 571.70M | 508.63M | 546.38M |
| Current Liabilities | 170.38M | 192.55M | 216.93M | 178.62M | 191.13M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#692 of 1052
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026